Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19
Completed
- Conditions
- Covid-19
- Registration Number
- NCT04446286
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Patient over the age of 18;
- Diagnostic COVID-19 by RT-PCR;
- Hospitalisation in resuscitation for the management of complications related to COVID-19
- Implanted ECMO-VV or VA during hospitalisation;
- Patient agreeing to participate in the study
Exclusion Criteria
- Sujet who has expressed opposition to participating in the study.
- Sujet under guardianship or trusteeship
- Sujet under safeguard of justice
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospective description of effect of the ECMO-VV or ECMO-VA in the management of severe ARDS refractory in patients of the Strasbourg and Louvain centres with covid-19 files analysed retrospectily from March 1st, 2020 to August 1st, 2020 will be examined
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
🇫🇷Strasbourg, France